350 related articles for article (PubMed ID: 15467031)
1. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
[TBL] [Abstract][Full Text] [Related]
2. Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers--The Shanghai Bladder Cancer Study.
Tao L; Day BW; Hu B; Xiang YB; Wang R; Stern MC; Gago-Dominguez M; Cortessis VK; Conti DV; Van Den Berg D; Pike MC; Gao YT; Yu MC; Yuan JM
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):937-45. PubMed ID: 23539508
[TBL] [Abstract][Full Text] [Related]
3. Nonsmoking-related arylamine exposure and bladder cancer risk.
Skipper PL; Tannenbaum SR; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
[TBL] [Abstract][Full Text] [Related]
4. Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes.
Leggett CS; Doll MA; States JC; Hein DW
Arch Toxicol; 2021 Jan; 95(1):311-319. PubMed ID: 33136180
[TBL] [Abstract][Full Text] [Related]
5. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
[TBL] [Abstract][Full Text] [Related]
6. Carotenoids/vitamin C and smoking-related bladder cancer.
Castelao JE; Yuan JM; Gago-Dominguez M; Skipper PL; Tannenbaum SR; Chan KK; Watson MA; Bell DA; Coetzee GA; Ross RK; Yu MC
Int J Cancer; 2004 Jun; 110(3):417-23. PubMed ID: 15095308
[TBL] [Abstract][Full Text] [Related]
7. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California.
Yu MC; Skipper PL; Taghizadeh K; Tannenbaum SR; Chan KK; Henderson BE; Ross RK
J Natl Cancer Inst; 1994 May; 86(9):712-6. PubMed ID: 8158701
[TBL] [Abstract][Full Text] [Related]
8. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
10. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
[TBL] [Abstract][Full Text] [Related]
11. Gender- and smoking-related bladder cancer risk.
Castelao JE; Yuan JM; Skipper PL; Tannenbaum SR; Gago-Dominguez M; Crowder JS; Ross RK; Yu MC
J Natl Cancer Inst; 2001 Apr; 93(7):538-45. PubMed ID: 11287448
[TBL] [Abstract][Full Text] [Related]
12. The use of biomarkers in epidemiology: the example of bladder cancer.
Vineis P
Toxicol Lett; 1992 Dec; 64-65 Spec No():463-7. PubMed ID: 1471198
[TBL] [Abstract][Full Text] [Related]
13. Aromatic amine DNA adduct formation in chronically-exposed mice: considerations for human comparison.
Poirier MC; Beland FA
Mutat Res; 1997 May; 376(1-2):177-84. PubMed ID: 9202754
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers.
Yu MC; Ross RK; Chan KK; Henderson BE; Skipper PL; Tannenbaum SR; Coetzee GA
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):861-4. PubMed ID: 8634658
[TBL] [Abstract][Full Text] [Related]
15. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers.
Hammond SK; Coghlin J; Gann PH; Paul M; Taghizadeh K; Skipper PL; Tannenbaum SR
J Natl Cancer Inst; 1993 Mar; 85(6):474-8. PubMed ID: 8445675
[TBL] [Abstract][Full Text] [Related]
16. Arylamine exposures and bladder cancer risk.
Yu MC; Skipper PL; Tannenbaum SR; Chan KK; Ross RK
Mutat Res; 2002 Sep; 506-507():21-8. PubMed ID: 12351141
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 4-aminobiphenyl-hemoglobin adducts in maternal and fetal blood-samples.
Myers SR; Spinnato JA; Pinorini-Godly MT; Cook C; Boles B; Rodgers GC
J Toxicol Environ Health; 1996 Apr; 47(6):553-66. PubMed ID: 8614023
[TBL] [Abstract][Full Text] [Related]
18. Interindividual variation in carcinogen metabolism and bladder cancer risk.
Vineis P; Ronco G
Environ Health Perspect; 1992 Nov; 98():95-9. PubMed ID: 1486869
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaine.
Gaber K; Harréus UA; Matthias C; Kleinsasser NH; Richter E
Toxicology; 2007 Jan; 229(1-2):157-64. PubMed ID: 17129655
[TBL] [Abstract][Full Text] [Related]
20. Analysis of 4-ABP-DNA adducts and p53 alterations in urinary bladder carcinoma.
Romano G; Garagnani L; Boninsegna A; Ferrari P; Flamini G; De Gaetani C; Sgambato A; Giovanni F; Curigliano G; Ferretti G; Cittadini A; Trentini G
Anticancer Res; 1999; 19(5C):4571-6. PubMed ID: 10650812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
